HUM.NYSEHumana INC

Form 4: Humana Director Brad D. Smith Reports Acquisition of Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Director Brad D. Smith reports acquisition of additional Humana stock units through director fees and dividend reinvestment.

Summary

  • Brad D. Smith, a director at Humana Inc., reported changes in beneficial ownership of Humana stock.
  • The report details the acquisition of restricted stock units (RSUs) through director's fees and dividend reinvestments.
  • On June 28, 2024, Smith acquired 84 RSUs at a price of $379.285 per unit, converting director's cash fees into stock units.
  • Smith also acquired 3 RSUs through dividend reinvestment on vested and deferred stock units.
  • The director holds 386 shares of Humana common stock directly.
  • Following the reported transactions, Smith beneficially owns 438 RSUs acquired from cash fees, 3 RSUs from dividend reinvestment, 430 RSUs from the company's 2019 Amended & Restated Plan, and 380 RSUs from annual director's fees.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The director's continued investment in the company through stock unit acquisitions is a positive signal, but the filing itself is a routine disclosure.

Positives

  • The acquisition of RSUs through director's fees and dividend reinvestment demonstrates the director's continued investment in the company.

Future Outlook

The report does not contain specific forward-looking statements, but it indicates continued director investment in Humana through stock unit acquisitions.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. This filing indicates a director's ongoing investment in the company, which can be viewed positively by investors.

Comparison to Industry Standards

  • Director stock ownership is a common practice in publicly traded companies like Humana.
  • Similar filings are regularly made by directors and officers of companies like UnitedHealth Group (UNH) and CVS Health (CVS).
  • The amounts and types of securities transactions are typical for director compensation and investment activities.

Stakeholder Impact

  • The report provides transparency to shareholders regarding director stock ownership.
  • It can influence investor sentiment positively, reflecting confidence from a company insider.

Key Dates

DateDescription
06/28/2024Date of transaction for acquiring 84 restricted stock units.
12/31/2024Vesting date for 100% of the 430 restricted stock units from the company's 2019 Amended & Restated Plan.
07/02/2024Date of report filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.